Author:
Starreveld Daniëlle E. J.,Daniels Laurien A.,Valdimarsdottir Heiddis B.,Redd William H.,de Geus Jessie L.,Ancoli-Israel Sonia,Lutgendorf Susan,Korse Catharina M.,Kieffer Jacobien M.,van Leeuwen Flora E.,Bleiker Eveline M. A.
Publisher
Springer Science and Business Media LLC
Subject
Cancer Research,Genetics,Oncology
Reference75 articles.
1. Favier O, Heutte N, Stamatoullas-Bastard A, Carde P, van't Veer MB, Aleman BM, Noordijk EM, Thomas J, Fermé C, Henry-Amar M, et al. Survival after Hodgkin lymphoma. Cancer. 2009;115(8):1680–91.
2. Pfreundschuh M, Trümper L, Österborg A, Pettengell R, Trneny M, Imrie K, Ma D, Gill D, Walewski J, Zinzani P-L. CHOP-like chemotherapy plus rituximab versus CHOP-like chemotherapy alone in young patients with good-prognosis diffuse large-B-cell lymphoma: a randomised controlled trial by the MabThera international trial (MInT) group. Lancet Oncol. 2006;7(5):379–91.
3. Aleman BM, van Leeuwen FE. Are we improving the long-term burden of Hodgkin's lymphoma patients with modern treatment? Hematol Oncol Clin North Am. 2007;21(5):961–75.
4. Mock V, Atkinson A, Barsevick A, Cella D, Cimprich B, Cleeland C, Donnelly J, Eisenberger M, Escalante C, Hinds P. NCCN practice guidelines for Cancer-related fatigue. Oncology (Williston Park, NY). 2000;14(11A):151–61.
5. Bower JE, Bak K, Berger A, Breitbart W, Escalante CP, Ganz PA, Schnipper HH, Lacchetti C, Ligibel JA, Lyman GH. Screening, assessment, and management of fatigue in adult survivors of cancer: an American Society of Clinical oncology clinical practice guideline adaptation. J Clin Oncol. 2014;32(17):1840–50.
Cited by
21 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献